Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2017

Nov 18, 2017

30561_dirs_2017-11-17_b3eca6c4-e1c9-4197-868c-bcb25532ecaf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2017-11-15

Reporting Person: Schwab Gisela (Pres Prod Dev & Med Aff & CMO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-15 Common Stock F 2609 $24.75 Disposed 255396 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 14186 Indirect

Footnotes

F1: Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016.

F2: Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of the most recent transaction date listed on this Form 4.